๐ฐ Presentation Details News
Page 2 - Presentation Details News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Presentation Details. Real-time updates on events, politics, business and more.
April 25, 2024
CellFE Inc., a life sciences tools company with a novel microfluidics-based cellular engineering platform, announced today an upcoming presentation by CSO Todd
April 25, 2024
CellFE Inc., a life sciences tools company with a novel microfluidics-based cellular engineering platform, announced today an upcoming presentation by CSO Todd
April 24, 2024
Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, today announced the acceptance...
April 23, 2024
WALTHAM, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
April 22, 2024
WALTHAM, Mass., April 22, 2024 -- TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment...
April 10, 2024
VANCOUVER, British Columbia, April 10, 2024 -- Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom Burton &...
April 5, 2024
NiKang Therapeutics Inc. ("NiKang"), a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet medical needs, announced today the unveiling of NKT3447 at the American Association...
April 5, 2024
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that it will present preclinical data for IM-3050, the...
March 25, 2024
ProteinQure Announces A Breakthrough Therapeutic with Remarkable Efficacy ...
February 22, 2024
22.02.2024 - Results of the Phase 2 trial of VTX002 (S1P1R modulator) in ulcerative colitis to be highlighted in oral presentation on February 22nd SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) - Ventyx Biosciences, Inc. (Nasdaq: VTYX) (โVentyxโ), a ... Seite 1